2016 ISHLT Annual Meeting and Scientific Sessions

Apr 27, 2016 ‐ Apr 30, 2016


Standard: $250.00

Sessions

PRE-MEETING SYMPOSIUM 01: Anticoagulation and MCS: Can We Do Better? -- Too Thick or Too Thin? Bleeding and Thrombosis in MCS

Apr 27, 2016 8:00am ‐ Apr 27, 2016 8:15am

Identification: PMSY01a

The goal of this symposium is to familiarize clinicians with current, widely available tests of blood coagulability and pitfalls in their interpretation in the MCS population. Additional topics will include comorbid states, such as acquired von Willebrand’s disease and genetic variations like Factor V mutations, and how they impact patients after device implantation.

Speaker(s):
  • Ulrich P. Jorde, MD, Montefiore Medical Center / Albert Einstein College of Medicine

PRE-MEETING SYMPOSIUM 02: Controversies in Heart Transplantation: Past, Present and Future -- Back to Basics: Pharmacology & Pharmacodynamics of Immunosuppressants

Apr 27, 2016 8:00am ‐ Apr 27, 2016 8:20am

Identification: PMSY02a

This session will review current immunosuppressant pharmacology as well as the current status of rejection surveillance. The utility of endomyocardial biopsy will be debated and then a report on future of heart transplant immunosuppression will be presented including perspectives on where the next advances will come from.

Speaker(s):
  • Tam Khuu, PharmD, BCPS, UCLA, Los Angeles, CA, United States

PRE-MEETING SYMPOSIUM 03: Current Innovations and Future of EVLP -- The Future of Lung Repair - Drug and Molecular Interventions during EVLP

Apr 27, 2016 8:00am ‐ Apr 27, 2016 8:15am

Identification: PMSY03a

This symposia will explore the prospect of gene, cell, drug and molecular interventions during EVLP to improve outcomes for lung transplant recipients. How essential EVLP is to the running of a modern day program will be debated.

Speaker(s):

PRE-MEETING SYMPOSIUM 04: Under Pressure: Pulmonary Hypertension in Parenchymal Lung Disease -- PH in ILD: Pathophysiology and Epidemiology

Apr 27, 2016 8:00am ‐ Apr 27, 2016 8:15am

Identification: PMSY04a

Cardiothoracic transplantation for patients with HIV, and hepatitis B and C remains a controversial topic. Historically, infection with any of these viruses was considered a relative or even absolute contraindication for transplantation. However, favorable experience in liver and kidney recipients has led some programs to progressively adjust selection criteria. The recent ISHLT listing criteria guidelines now include HIV, HCV and HBV positive patients and more programs are performing transplantation in these complex populations. Having a current understanding of these diseases, therapy and monitoring will assist the transplant team.  This includes knowledge of drug interactions and the concerns for the various types of  immunosuppression (Induction, maintenance) on these patients and if there are preferred agents to use.  Lastly developing an approach with an understanding of how to manage complications is necessary for success. Therefore, the focus of this symposium is to increase the knowledge of the CT transplant community about the management and pharmacological treatment options for CT transplants candidates with HIV, hepatitis B or C, before and after transplant.

Speaker(s):
  • John Granton, MD, University of Toronto, Toronto, ON, Canada

PRE-MEETING SYMPOSIUM 05: Making It Work: Heart Transplant Challenges from the Surgeon's Perspective -- Out of Time: Surgical Options for Late Graft Failure

Apr 27, 2016 8:00am ‐ Apr 27, 2016 8:20am

Identification: PMSY05a

To discuss the controversies, advances, and new directions in heart transplant surgery.

Speaker(s):
  • Vivek Rao, MD, PhD, Toronto General Hospital

PRE-MEETING SYMPOSIUM 06: Back to the Future: Cell Therapy for Thoracic Organ Failure and Transplant? -- Tissue Engineering for Dummies: How to Build a Heart or Lung

Apr 27, 2016 8:00am ‐ Apr 27, 2016 8:15am

Identification: PMSY06a

This session will focus on cutting edge therapies that involve cells. There will be a focus on using cells to repair or fully regenerate a failing organ, for transplant tolerance induction or treatment of chronic rejection.

Speaker(s):
  • Doris Taylor, PhD, FAHA, FACC, Texas Heart Institute, Houston, TX, United States

PRE-MEETING SYMPOSIUM 07: The Future is Here: Emerging Issues in Infectious Disease -- Mycobacterium Abscessus and Friends

Apr 27, 2016 8:00am ‐ Apr 27, 2016 8:15am

Identification: PMSY07a

This symposium will explore the emergence and resurgence of difficult to treat pathogens in thoracic transplant and MCSD patients that challenge practitioners worldwide.

Speaker(s):
  • Fernanda Silveira, MD, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

PRE-MEETING SYMPOSIUM 01: Anticoagulation and MCS: Can We Do Better? -- Pre-operative Genetic Screening for Coagulation Abnormalities and Impact on Post-operative Management

Apr 27, 2016 8:20am ‐ Apr 27, 2016 8:35am

Identification: PMSY01b

The goal of this symposium is to familiarize clinicians with current, widely available tests of blood coagulability and pitfalls in their interpretation in the MCS population. Additional topics will include comorbid states, such as acquired von Willebrand’s disease and genetic variations like Factor V mutations, and how they impact patients after device implantation.

Speaker(s):

PRE-MEETING SYMPOSIUM 02: Controversies in Heart Transplantation: Past, Present and Future -- Putting it Together: Approaches to Immune Monitoring

Apr 27, 2016 8:20am ‐ Apr 27, 2016 8:40am

Identification: PMSY02b

This session will review current immunosuppressant pharmacology as well as the current status of rejection surveillance. The utility of endomyocardial biopsy will be debated and then a report on future of heart transplant immunosuppression will be presented including perspectives on where the next advances will come from.

Speaker(s):
  • Michael Pham, MD, MPH, California Pacific Medical Center, San Francisco, CA, United States

PRE-MEETING SYMPOSIUM 05: Making It Work: Heart Transplant Challenges from the Surgeon's Perspective -- Surgical Management of Cardiac Primary Graft Dysfunction

Apr 27, 2016 8:20am ‐ Apr 27, 2016 8:40am

Identification: PMSY05b

To discuss the controversies, advances, and new directions in heart transplant surgery.

Speaker(s):
Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content